EUR 3.55
(-2.74%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 46.34 Million EUR | -82.07% |
2022 | 47.59 Million EUR | 49.47% |
2021 | 31.84 Million EUR | 44.3% |
2020 | 22.06 Million EUR | 31.82% |
2019 | 16.73 Million EUR | -22.22% |
2018 | 21.52 Million EUR | -12.29% |
2017 | 24.53 Million EUR | 58.9% |
2016 | 15.44 Million EUR | 63.2% |
2015 | 9.46 Million EUR | 105.2% |
2014 | 4.61 Million EUR | -30.01% |
2013 | 6.58 Million EUR | 10.43% |
2012 | 5.96 Million EUR | 99.76% |
2011 | 2.98 Million EUR | -19.04% |
2010 | 3.68 Million EUR | 3.64% |
2009 | 3.55 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 4.86 Million EUR | 0.0% |
2023 Q2 | 3.9 Million EUR | 0.0% |
2023 Q4 | 11.58 Million EUR | 0.0% |
2023 FY | 8.53 Million EUR | -82.07% |
2022 Q4 | 3.81 Million EUR | 0.0% |
2022 FY | 47.59 Million EUR | 49.47% |
2022 Q2 | 3.21 Million EUR | 0.0% |
2021 Q4 | 2 Million EUR | 0.0% |
2021 FY | 31.84 Million EUR | 44.3% |
2021 Q2 | 1.99 Million EUR | 0.0% |
2020 Q2 | 1.64 Million EUR | 0.0% |
2020 Q4 | 1.56 Million EUR | 0.0% |
2020 FY | 22.06 Million EUR | 31.82% |
2019 Q2 | 4.03 Million EUR | 0.0% |
2019 FY | 16.73 Million EUR | -22.22% |
2019 Q4 | 1.84 Million EUR | 0.0% |
2018 Q4 | 5.16 Million EUR | 0.0% |
2018 FY | 21.52 Million EUR | -12.29% |
2018 Q2 | 5.89 Million EUR | 0.0% |
2017 FY | 24.53 Million EUR | 58.9% |
2017 Q4 | 4.77 Million EUR | 0.0% |
2017 Q2 | 5.03 Million EUR | 0.0% |
2016 FY | 15.44 Million EUR | 63.2% |
2016 Q2 | 2.73 Million EUR | 0.0% |
2016 Q4 | 4.03 Million EUR | 0.0% |
2015 Q2 | 1.36 Million EUR | 0.0% |
2015 FY | 9.46 Million EUR | 105.2% |
2015 Q4 | 2.36 Million EUR | 0.0% |
2014 FY | 4.61 Million EUR | -30.01% |
2014 Q4 | 1.3 Million EUR | 0.0% |
2014 Q2 | 878 Thousand EUR | 0.0% |
2013 Q2 | 902.99 Thousand EUR | 0.0% |
2013 Q4 | 55.03 Thousand EUR | 0.0% |
2013 FY | 6.58 Million EUR | 10.43% |
2012 Q4 | - EUR | 0.0% |
2012 FY | 5.96 Million EUR | 99.76% |
2012 Q2 | - EUR | 0.0% |
2011 Q4 | - EUR | 0.0% |
2011 FY | 2.98 Million EUR | -19.04% |
2010 FY | 3.68 Million EUR | 3.64% |
2009 FY | 3.55 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | -290.544% |
Bluelinea Société Anonyme | 11.43 Thousand EUR | -405022.825% |
Carmat SA | 21.54 Million EUR | -115.064% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | -155.92% |
Euromedis Groupe | 17.6 Million EUR | -163.169% |
Eurobio Scientific Société anonyme | 47.34 Million EUR | 2.123% |
Ikonisys S.A. | 2.44 Million EUR | -1791.853% |
Implanet S.A. | 9.29 Million EUR | -398.784% |
SpineGuard SA | 7.35 Million EUR | -530.062% |
Theraclion SA | -1.08 Million EUR | 4389.397% |
Euroapi S.A. | 398.9 Million EUR | 88.383% |
Guerbet SA | 550.79 Million EUR | 91.586% |
Ion Beam Applications SA | 128.02 Million EUR | 63.802% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 99.207% |
Sequana Medical NV | 30.03 Million EUR | -54.27% |